Clinical Trial

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to evaluate what effect, if any, mismatched unrelated volunteer donor and/or haploidentical related donor stem cell transplant may have on severe sickle cell disease and other transfusion dependent anemias. By using mismatched unrelated volunteer donor and/or haploidentical related donor stem cells, this study will increase the number of patients who can undergo a stem cell transplant for their specified disease. Additionally, using a T-cell depleted approach should reduce the incidence of graft-versus-host disease which would otherwise be increased in a mismatched transplant setting.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-08-01 -> 2028-08-01 2026-08-14
minor Completion pushed: 2027-08-01 -> 2028-08-01 2026-08-14
Trial Details
NCT Number NCT03653338
Lead Sponsor Paul Szabolcs
Conditions Sickle Cell Anemia, Beta-thalassemia Major, Diamond-blackfan Anemia
Enrollment 5 participants
Start Date 2018-08-02
Primary Completion 2028-08-01 (estimated)
Study Completion 2028-08-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-13